Hong Li
Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
More InformationCorresponding author: E-mail address: Hong.Li@emory.edu (Hong Li)
Received Date: 2017-10-06
Accepted Date:2018-02-11
Rev Recd Date:2017-11-14
Available Online: 2018-02-14 Publish Date:2018-02-20
Abstract
Abstract
Inborn errors of metabolism (IEMs) are a large group of inherited disorders characterized by disruption of metabolic pathways due to deficient enzymes, cofactors, or transporters. The rapid advances in the understanding of the molecular pathophysiology of many IEMs, have led to significant progress in the development of many new treatments. The institution and continued expansion of newborn screening provide the opportunity for early treatment, leading to reduced morbidity and mortality. This review provides an overview of the diverse therapeutic approaches and recent advances in the treatment of IEMs that focus on the basic principles of reducing substrate accumulation, replacing or enhancing absent or reduced enzyme or cofactor, and supplementing product deficiency. In addition, the challenges and obstacles of current treatment modalities and future treatment perspectives are reviewed and discussed.Keywords: Inborn errors of metabolism,
Treatment,
Dietary therapy,
Enzyme replacement therapy,
Substrate reduction therapy,
Pharmacological chaperone therapy
PDF全文下载地址:
http://www.jgenetgenomics.org/article/exportPdf?id=3e5dc0ea-c142-4552-a230-2e088484ab14&language=en
